Why is Remedium Life falling/rising?

As of 23-Jun, Remedium Lifecare Ltd's stock price is currently at Rs 0.88, reflecting a decrease of Rs 0.04 or 4.35%. The stock has significantly underperformed, with a 1-week return of -15.38% and a staggering 1-month return of -47.93%. Today's performance indicates that it is trading lower than all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, the stock is close to its 52-week low, being only 1.14% away from Rs 0.87. The company has reported negative financial results over the past three quarters, with a high Debt to EBITDA ratio of -1.00 times and a negative return on capital employed (ROCE). These factors contribute to a perception of poor financial health and growth prospects, leading to a decline in stock price.
In the broader market context, the Sensex has shown a slight increase of 0.12% over the past week, contrasting sharply with Remedium's decline. This indicates that the stock's poor performance is not reflective of the overall market trend. The company's negative financial indicators, including a 94.21% drop in net sales and a 96.31% decline in profit after tax, further exacerbate its situation. Despite a rise in investor participation, the stock's liquidity remains low, and its ability to service debt is questionable, making it a risky investment. Overall, the combination of negative financial results and underperformance relative to the benchmark suggests that the stock is facing significant challenges.